Zota Healthcare Share Price Today | Stock Price & Zota Healthcare Share Screener
As of October 5, 2026, the live Zota Healthcare share price (NSE: ZOTA) is ₹1,297.40, up 2.33% from the previous close, with shares trading between ₹1,247.40 and ₹1,313.90 in today's trading session, and a 52-week range of ₹1,028.10–₹1,687.00. Check ZOTA price range for the annual price range and momentum. Use the Zota Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Zota Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹176 and net income of ₹-44, with EBITDA of ₹-10, an operating margin of -7.0% and a profit margin of -25.0%.
Zota Healthcare Share Price Chart
Track the current stock price of Zota Healthcare with an interactive chart. Analyse ZOTA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Zota Healthcare stock quote in one place.
The quote of ₹1,297.40 sits between the 52-week low of ₹1,028.10 and the 52-week high of ₹1,687.00, and the latest session moved 2.33% from the previous close.
Zota Healthcare Company Profile - Fundamental Screener
Screen Zota Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZOTA shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE358U01012.
Company Details
Classification
Identifiers and Leadership
Zota Healthcare Balance Sheet Screener
Screen ZOTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹1,131, up from ₹439 in 2025.
Latest statistics put total assets at ₹1,131 and shareholder funds at ₹696, with a leverage ratio of 0.45.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2015 |
|---|---|---|---|---|---|---|---|---|---|
Assets |
|||||||||
| Total Assets | 1,131 | 439 | 228 | 158 | 139 | 86 | 89 | 90 | 40 |
| Current Assets | 457 | 184 | 112 | 84 | 77 | 61 | 59 | 62 | 32 |
| Fixed Assets | 369 | 185 | 103 | 62 | 29 | 14 | 15 | 10 | 8 |
Liabilities |
|||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 198 | 111 | 65 | 37 | 14 | 1 | 1 | 1 | 3 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||||||
| Total Equity | 696 | 227 | 90 | 80 | 90 | 66 | 69 | 69 | 18 |
| Share Capital | 35 | 29 | 26 | 25 | 25 | 25 | 25 | 18 | 14 |
| Reserves & Surplus | 659 | 195 | 64 | 55 | 65 | 42 | 44 | 51 | 4 |
Zota Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Zota Healthcare income statement and profit fundamentals. Analyze ZOTA quarterly results. Zota Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹176 and net profit was ₹-44, equal to earnings per unit of ₹-12.58, at an operating margin of -7%.
In that period expenses were ₹185, interest cost ₹6 and tax ₹0. The next period listed, 2026-Mar, shows revenue of ₹166 and net profit of ₹-15.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 176 | 166 | 145 | 131 | 105 | 98 | 73 | 68 | 56 | 50 | 47 | 46 | 39 | 37 | 36 |
| Expenses | 185 | 161 | 143 | 123 | 100 | 95 | 78 | 68 | 58 | 51 | 44 | 41 | 37 | 36 | 35 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | -10 | 6 | 1 | 8 | 5 | 4 | -6 | 0 | -1 | -1 | 4 | 5 | 1 | 2 | 1 |
| Operating Profit % | -7.00% | 2.00% | 0.00% | 5.00% | 4.00% | 3.00% | -8.00% | -1.00% | -2.00% | -3.00% | 7.00% | 10.00% | 3.00% | 3.00% | 0.00% |
| Depreciation | 28 | 27 | 22 | 19 | 15 | 14 | 11 | 10 | 8 | 7 | 5 | 5 | 3 | 4 | 3 |
| Interest | 6 | 5 | 5 | 4 | 3 | 4 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -44 | -26 | -26 | -14 | -13 | -14 | -19 | -13 | -12 | -10 | -3 | -1 | -3 | -3 | -3 |
| Tax | 0 | -12 | 4 | 2 | 1 | -1 | 1 | -1 | 1 | -3 | 0 | 1 | 0 | -1 | 0 |
| Net Profit | -44 | -15 | -30 | -16 | -14 | -13 | -19 | -12 | -13 | -7 | -3 | -2 | -3 | -3 | -3 |
| EPS | -12.58 | -4.13 | -9.44 | -5.26 | -4.92 | -4.57 | -6.80 | -4.57 | -4.80 | -2.68 | -1.14 | -0.64 | -1.13 | -1.05 | -1.28 |
Zota Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen ZOTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹82, and net cash flow was an inflow of ₹92.
Over the same period, investing activities used ₹330 and financing activities provided ₹503.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | |||||||||
| Operating Activities | -82 | -50 | -6 | -2 | 13 | -1 | 6 | -3 | 5 |
| Investing Activities | -330 | -92 | -13 | 15 | -27 | 4 | -4 | 9 | -1 |
Financing and Net Cash | |||||||||
| Financing Activities | 503 | 145 | 19 | -14 | 14 | -2 | -3 | -6 | -4 |
| Net Cash Flow | 92 | 3 | 0 | -1 | 1 | 1 | -1 | -1 | 0 |
Zota Healthcare Shareholding Pattern Screener
See Zota Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Zota Healthcare promoter holding and ownership changes for ZOTA on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 49.38%, foreign institutions 7.88%, domestic institutions 7.04% and the public 27.84%, spread across 14,005 shareholders.
The shareholder count was 14,005 in 2026-Mar, compared with 14,678 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Feb | 2025-Mar | 2025-Apr | 2025-Jun | 2025-Sept | 2025-Dec |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 49.38% | 49.38% | 59.72% | 59.72% | 58.11% | 57.42% | 55.81% | 50.64% |
Institutional Investors | ||||||||
| FII Holding | 7.88% | 7.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 8.09% |
| DII Holding | 7.04% | 6.75% | 0.03% | 0.03% | 0.00% | 0.00% | 0.06% | 7.22% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 27.84% | 28.20% | 25.23% | 25.52% | 24.79% | 24.10% | 25.25% | 26.16% |
| Other Holding | 7.85% | 7.76% | 15.02% | 14.72% | 17.10% | 18.49% | 18.88% | 7.89% |
| Shareholder Count | 14,005 | 14,678 | 10,324 | 10,389 | 10,382 | 10,354 | 11,855 | 13,092 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Zota Healthcare. Zota Healthcare dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹1.00 per unit for 2026-March, a yield of 0.08%, compared with ₹1.00 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹1.00, ₹1.00 and ₹1.00 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹1.00 | 0.08% |
| 2025-March | ₹1.00 | 0.09% |
| 2024-March | ₹1.00 | 0.12% |
| 2023-March | ₹1.00 | 0.21% |
| 2022-March | ₹1.50 | 0.52% |
| 2021-March | ₹1.00 | 0.34% |
| 2020-March | ₹1.00 | 0.72% |
| 2019-March | ₹1.00 | 0.77% |
| 2018-March | ₹3.00 | 1.62% |
| 2017-March | ₹2.00 | 1.30% |
Zota Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Zota Healthcare stock. Check ZOTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Zota Healthcare Market Events Screener - Corporate Actions
Get Zota Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Zota Healthcare stock events that may affect ZOTA share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Dividend dated September 21, 2026, with a record date of September 21, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 22, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-21 | 2026-09-21 | Dividend | ₹ 1.00 /share | -5.90% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -0.16% |
| 2026-05-22 | 2026-05-22 | Quarterly Result Announcement | NA | 1.10% |
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | -0.36% |
| 2025-10-17 | 2025-10-17 | Quarterly Result Announcement | NA | 5.54% |
| 2025-09-22 | 2025-09-22 | Dividend | ₹ 1.00 /share | 44.22% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.17% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.18% |
| 2025-03-26 | 2025-03-26 | Extraordinary General Meeting | NA | -0.73% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -3.90% |
| 2025-02-05 | 2025-02-05 | Extraordinary General Meeting | NA | 2.37% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -6.86% |
| 2024-09-28 | 2024-09-28 | Annual General Meeting | NA | -8.85% |
| 2024-09-20 | 2024-09-21 | Dividend | ₹ 1.00 /share | 39.65% |
| 2024-07-13 | 2024-07-13 | Extraordinary General Meeting | NA | -8.92% |
Zota Healthcare Competitors Screener - Peer Stocks Comparison
Screen ZOTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 439,678 | 36.83 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 248,213 | 86.00 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 183,889 | 86.72 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 115,760 | 25.96 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 110,248 | 33.29 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,685 | 98.39 | 6,868 | 22.01% | 890 | 58.00 |
| Dr Reddys Laboratories | 102,674 | 32.77 | 35,059 | 3.90% | 4,158 | 69.59 |
| Mankind Pharma | 102,415 | 50.84 | 14,636 | 14.85% | 1,938 | 64.24 |
| Aurobindo Pharma | 96,548 | 26.41 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,196 | 16.97 | 29,039 | 26.75% | 5,356 | 34.02 |
Zota Healthcare Company Announcements - News & Reports Screener
Screen ZOTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 3, 2026.
The next most recent announcements are dated October 3, 2026 and September 29, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-03 | Trading Window | - |
| 2026-10-03 | Shareholders meeting | - |
| 2026-09-29 | General Updates | - |
| 2026-09-26 | Updates | - |
| 2026-09-18 | Cessation | - |
| 2026-09-06 | Copy of Newspaper Publication | - |
| 2026-09-04 | Copy of Newspaper Publication | - |
| 2026-09-03 | Shareholders meeting | - |
| 2026-09-03 | Record Date | - |
| 2026-09-03 | Appointment | - |
| 2026-09-03 | Outcome of Board Meeting | - |
| 2026-08-20 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2026-08-15 | Copy of Newspaper Publication | - |
| 2026-08-14 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
| 2026-08-14 | Monitoring Agency Report | - |
| 2026-08-13 | Press Release | - |
| 2026-08-13 | Statement of deviation(s) or variation(s) under Reg. 32 | - |
| 2026-08-13 | Outcome of Board Meeting | - |
| 2026-08-13 | Investor Presentation | - |
| 2026-08-06 | Analysts/Institutional Investor Meet/Con. Call Updates | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹1,297.40, within a 52-week range of ₹1,028.10 to ₹1,687.00. The P/E ratio is -43.20 and the P/B ratio is 6.49, with earnings per unit of ₹-22.46. Market capitalisation stands at ₹4,485.96 Cr and the dividend yield is 0.08%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE. Key statistics were last updated on October 5, 2026. This page covers 9 balance sheet periods, 15 income statement periods, 9 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.